Moderna Total Cost of Revenue increased by 111.3% to $955.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 961.1%, from $90.00M to $955.00M. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows a downward trend with a -24.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $750.00M | $722.00M | $952.00M | $1.02B | $1.38B | $1.10B | $1.92B | $792.00M | $731.00M | $2.24B | $929.00M | $96.00M | $115.00M | $514.00M | $739.00M | $90.00M | $119.00M | $207.00M | $452.00M | $955.00M |
| QoQ Change | — | -3.7% | +31.9% | +6.8% | +35.8% | -20.3% | +74.4% | -58.7% | -7.7% | +206.6% | -58.5% | -89.7% | +19.8% | +347.0% | +43.8% | -87.8% | +32.2% | +73.9% | +118.4% | +111.3% |
| YoY Change | — | — | — | — | +84.1% | +52.4% | +101.5% | -22.1% | -47.1% | +103.7% | -51.6% | -87.9% | -84.3% | -77.1% | -20.5% | -6.3% | +3.5% | -59.7% | -38.8% | +961.1% |